On 29 July 2016
Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 July 2016 to consider and approve the Unaudited Financial Results of the Company for the quarter ended on June 30, 2016 (Q1).Powered by Capital Market - Live News
